|
|
Blood, 15 December 2004, Vol. 104, No. 13, pp. 3958-3964.
Prepublished online as a Blood First Edition Paper on August 19, 2004; DOI 10.1182/blood-2004-03-1203.
Previous Article | Table of Contents | Next Article 
HEMOSTASIS, THROMBOSIS, AND VASCULAR BIOLOGY
Patients with severe sepsis vary markedly in their ability to generate activated protein C
Patricia C. Y. Liaw,
Charles T. Esmon,
Kamyar Kahnamoui,
Shelley Schmidt,
Sarah Kahnamoui,
Gary Ferrell,
Suzanne Beaudin,
Jim A. Julian,
Jeffrey I. Weitz,
Mark Crowther,
Mark Loeb, and
Deborah Cook
From the Departments of Medicine, Biochemistry, Clinical Epidemiology and Biostatistics, Surgery, and Pathology and Molecular Medicine, McMaster University, Hamilton, Ontario, and the Henderson Research Centre, Hamilton, Ontario, and the Cardiovascular Biology Research Program, Oklahoma Medical Research Foundation, and the Departments of Pathology, and Biochemistry and Molecular Biology, University of Oklahoma Health Sciences Center, and the Howard Hughes Medical Institute, Oklahoma City, OK.
Activated protein C (APC) supplementation significantly reduces mortality in patients with severe sepsis, presumably by down-regulating coagulation, inflammation, and apoptosis. In vivo, endogenous APC is generated from protein C (PC) "on demand" in response to elevated thrombin levels. Thrombomodulin and endothelial cell protein C receptor are endothelial receptors required to generate APC endogenously. Since these receptors may be down-regulated in sepsis, we measured plasma markers of APC generation in 32 patients with severe sepsis to determine whether APC generation is impaired and whether markers of APC generation correlate with 28-day mortality. Relative to normals, all patients had elevated F1 + 2 and thrombin-antithrombin complex (TAT) levels (markers of thrombin generation and inhibition, respectively), and 28 of 32 patients had reduced PC levels. In 20 patients, APC levels paralleled elevated F1 + 2 levels, whereas 12 patients had low APC levels despite elevated F1 + 2 levels, suggesting that APC generation is impaired in the latter. No significant differences exist between survivors and nonsurvivors with respect to baseline PC levels, F1 + 2 levels, and APACHE II (acute physiology and chronic health evaluation) scores. Baseline APC levels were higher in survivors (P = .024), and baseline F1 + 2/APC ratios were lower in survivors (P = .047). Larger studies are warranted to establish whether APC generation profiles aid in managing sepsis. (Blood. 2004;104:3958-3964)

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
Related Article in Blood Online:
-
APC: braking neutrophils to benefit patients?
- Joseph P. Mizgerd
Blood 2004 104: 3841.
[Full Text]
[PDF]
This article has been cited by other articles:

|
 |

|
 |
 
M. Schouten, W. J. Wiersinga, M. Levi, and T. van der Poll
Inflammation, endothelium, and coagulation in sepsis
J. Leukoc. Biol.,
March 1, 2008;
83(3):
536 - 545.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. E. Ventetuolo and M. M. Levy
Sepsis: A Clinical Update
Clin. J. Am. Soc. Nephrol.,
March 1, 2008;
3(2):
571 - 577.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Borgel, C. Bornstain, P. H. Reitsma, N. Lerolle, S. Gandrille, F. Dali-Ali, C. T. Esmon, J.-Y. Fagon, M. Aiach, and J.-L. Diehl
A Comparative Study of the Protein C Pathway in Septic and Nonseptic Patients with Organ Failure
Am. J. Respir. Crit. Care Med.,
November 1, 2007;
176(9):
878 - 885.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. J. Kerschen, J. A. Fernandez, B. C. Cooley, X. V. Yang, R. Sood, L. O. Mosnier, F. J. Castellino, N. Mackman, J. H. Griffin, and H. Weiler
Endotoxemia and sepsis mortality reduction by non-anticoagulant activated protein C
J. Exp. Med.,
October 1, 2007;
204(10):
2439 - 2448.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. A. Kowalska, S. A. Mahmud, M. P. Lambert, M. Poncz, and A. Slungaard
Endogenous platelet factor 4 stimulates activated protein C generation in vivo and improves survival after thrombin or lipopolysaccharide challenge
Blood,
September 15, 2007;
110(6):
1903 - 1905.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Tang, L. Ivanciu, N. Popescu, G. Peer, E. Hack, C. Lupu, F. B. Taylor Jr, and F. Lupu
Sepsis-Induced Coagulation in the Baboon Lung Is Associated with Decreased Tissue Factor Pathway Inhibitor
Am. J. Pathol.,
September 1, 2007;
171(3):
1066 - 1077.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Wang, J. A. Bastarache, N. Wickersham, X. Fang, M. A. Matthay, and L. B. Ware
Novel Role of the Human Alveolar Epithelium in Regulating Intra-Alveolar Coagulation
Am. J. Respir. Cell Mol. Biol.,
April 1, 2007;
36(4):
497 - 503.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. J. Lay, D. Donahue, M.-J. Tsai, and F. J. Castellino
Acute inflammation is exacerbated in mice genetically predisposed to a severe protein C deficiency
Blood,
March 1, 2007;
109(5):
1984 - 1991.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
X. Zheng, W. Li, J.-M. Gu, D. Qu, G. L. Ferrell, N. L. Esmon, and C. T. Esmon
Effects of membrane and soluble EPCR on the hemostatic balance and endotoxemia in mice
Blood,
February 1, 2007;
109(3):
1003 - 1009.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Raivio, J. A. Fernandez, A. Kuitunen, J. H. Griffin, R. Lassila, and J. Petaja
Activation of protein C and hemodynamic recovery after coronary artery bypass surgery
J. Thorac. Cardiovasc. Surg.,
January 1, 2007;
133(1):
44 - 51.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Taneja and D. C. Cheng
Con: Heparin-Bonded Cardiopulmonary Bypass Circuits Should Be Routine for All Cardiac Surgical Procedures
Anesth. Analg.,
December 1, 2006;
103(6):
1370 - 1372.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. A. Russell
Management of Sepsis
N. Engl. J. Med.,
October 19, 2006;
355(16):
1699 - 1713.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Feistritzer, R. A. Schuepbach, L. O. Mosnier, L. A. Bush, E. Di Cera, J. H. Griffin, and M. Riewald
Protective Signaling by Activated Protein C Is Mechanistically Linked to Protein C Activation on Endothelial Cells
J. Biol. Chem.,
July 21, 2006;
281(29):
20077 - 20084.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Yano, P. C. Liaw, J. M. Mullington, S.-C. Shih, H. Okada, N. Bodyak, P. M. Kang, L. Toltl, B. Belikoff, J. Buras, et al.
Vascular endothelial growth factor is an important determinant of sepsis morbidity and mortality
J. Exp. Med.,
June 12, 2006;
203(6):
1447 - 1458.
[Abstract]
[Full Text]
[PDF]
|
 |
|
| |